Clozapine Prolongs Cortical Silent Period in Patients with Treatment-Resistant Schizophrenia

OBJECTIVES: Although clozapine exhibited high efficacy for treating the symptoms of patients with treatment-resistant schizophrenia (TRS), its precise action mechanisms have not been fully understood. Recently, accumulating evidence has suggested the presence of abnormalities in the gamma-aminobutyr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacol Bull
Main Authors: Miyazawa, Atsuhiro, Kanahara, Nobuhisa, Nakata, Yusuke, Kodama, Satoshi, Kimura, Hiroshi, Kimura, Atsushi, Oda, Yasunori, Watanabe, Hiroyuki, Iyo, Masaomi
Formato: Artigo
Idioma:Inglês
Publicado em: MedWorks Media Global 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146563/
https://ncbi.nlm.nih.gov/pubmed/34092820
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados